3Indexed trials
drug · Product Intelligence
rasagiline mesylate
Pipeline Intelligence
rasagiline mesylate: 3 indexed trials, 1 sponsors; 2 linked Orange Book patents and 10 FDA-linked events where matched.
1Sponsors
2Orange Book patent links
10FDA-linked events
Development evidence
NCT00203125Teva Branded Pharmaceutical Products R&D, Inc. · parkinsonsPHASE3
NCT00203138Teva Branded Pharmaceutical Products R&D, Inc. · parkinsonsPHASE3
NCT00936676Teva Branded Pharmaceutical Products R&D, Inc. · parkinsonsCOMPLETED
FDA / patent evidence
7815942AZILECT · app 0216412027-08-27
7572834AZILECT · app 0216412026-12-05
Regulatory context
FDA_APPROVALRASAGILINE MESYLATE · 2025-05-05
FDA_APPROVALRASAGILINE MESYLATE · 2024-06-28
FDA_APPROVALRASAGILINE MESYLATE · 2024-04-09
FDA_APPROVALRASAGILINE MESYLATE · 2021-11-18
FDA_APPROVALRASAGILINE MESYLATE · 2019-03-29
FDA_APPROVALRASAGILINE MESYLATE · 2018-07-27
FDA_APPROVALRASAGILINE MESYLATE · 2017-10-30
FDA_APPROVALRASAGILINE MESYLATE · 2013-09-12
FDA_APPROVALRASAGILINE MESYLATE · 2013-07-01
FDA_APPROVALAZILECT · 2006-05-16
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.